US4391755A
(en)
*
|
1982-01-18 |
1983-07-05 |
E. R. Squibb & Sons, Inc. |
Steroid monohydrates, formulations containing same and method
|
US4530840A
(en)
*
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
JPS5995300A
(ja)
*
|
1982-11-02 |
1984-06-01 |
スタ−リング・ドラッグ・インコ−ポレ−テッド |
コントロ−ルされた粒度の2−シアノ−4,5−エポキシ−3−オキソ−ステロイド類およびそれらの組成物
|
US5140021A
(en)
*
|
1986-04-16 |
1992-08-18 |
Genesis Systems Corporation |
Method and dosage form for treatment of premenstrual syndrome
|
US4963540A
(en)
*
|
1986-04-16 |
1990-10-16 |
Maxson Wayne S |
Method for treatment of premenstrual syndrome
|
US6024983A
(en)
*
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
US4927816A
(en)
*
|
1987-08-20 |
1990-05-22 |
Ester George C |
Formulae and methods for sublingual ingestion of natural progesterone
|
US4900734A
(en)
*
|
1987-08-27 |
1990-02-13 |
Maxson Wayne S |
Novel pharmaceutical composition containing estradiol and progesterone for oral administration
|
EP0335970B1
(fr)
*
|
1987-10-05 |
1992-09-02 |
Pharmagyn, Inc. |
Comprime utilise dans le traitement de carences en progesterone
|
US5093265A
(en)
*
|
1987-12-16 |
1992-03-03 |
Genesis Systems Corporation |
Method for detecting of premenstrual syndrome
|
DK95093D0
(da)
|
1993-08-20 |
1993-08-20 |
Novo Nordisk As |
Farmaceutisk formulering indeholdende et hormon
|
US5618845A
(en)
*
|
1994-10-06 |
1997-04-08 |
Cephalon, Inc. |
Acetamide derivative having defined particle size
|
DE19603402A1
(de)
*
|
1995-02-24 |
1996-08-29 |
Basf Ag |
Weichgelatinekapseln
|
MX9706449A
(es)
*
|
1995-02-28 |
1997-11-29 |
Hoechst Marion Roussel Inc |
Composicion farmaceutica para compuestos de piperidinalcanol.
|
FR2747042B1
(fr)
*
|
1996-04-05 |
1998-06-05 |
Besins Iscovesco Lab |
Medicament a base de progesterone et d'oestradiol
|
WO1999009957A1
(fr)
*
|
1997-08-26 |
1999-03-04 |
Hoechst Marion Roussel, Inc. |
Composition pharmaceutique associant piperidino-alcanol et decongestionnant
|
FR2772617B1
(fr)
*
|
1997-12-19 |
2001-03-09 |
Besins Iscovesco Lab |
Comprime de progesterone et son procede de preparation
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6787531B1
(en)
*
|
1999-08-31 |
2004-09-07 |
Schering Ag |
Pharmaceutical composition for use as a contraceptive
|
US20020132801A1
(en)
*
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
EP1475093B1
(fr)
|
2000-04-24 |
2006-09-06 |
Teva Pharmaceutical Industries Ltd. |
Zolpidem Hemitartrate micronisé
|
AU5721301A
(en)
*
|
2000-04-24 |
2001-11-07 |
Teva Pharma |
Zolpidem hemitartrate
|
US20040229854A1
(en)
*
|
2000-11-28 |
2004-11-18 |
Pieter Haan De |
Immediate release dosage form for HRT
|
FR2821555B1
(fr)
*
|
2001-03-01 |
2003-05-16 |
Besins Int Lab |
Progestatif co-micronise avec un tensioactif, composition pharmaceutique le comprenant, leurs procedes de fabrication et leurs utilisations
|
GB2375958B
(en)
*
|
2001-04-09 |
2005-03-02 |
George Margetts |
The use of steroids to lower the levels of cortisol
|
FR2832065B1
(fr)
*
|
2001-11-13 |
2004-11-05 |
Besins Int Belgique |
Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
|
US20040048931A1
(en)
*
|
2002-07-12 |
2004-03-11 |
Craig Heacock |
Modafinil pharmaceutical compositions
|
US20040115287A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Lipocine, Inc. |
Hydrophobic active agent compositions and methods
|
US7572780B2
(en)
*
|
2003-01-21 |
2009-08-11 |
Dimera, Incorporated |
Method and kit for reducing the symptoms of peripheral vascular disease
|
GB2400554B
(en)
*
|
2003-04-16 |
2007-04-18 |
George Margetts |
Treatment of angiotensin II-induced cardiovascular disease
|
US20040253308A1
(en)
*
|
2003-04-29 |
2004-12-16 |
Barr Laboratories, Inc. |
Surface-treated modafinil particles
|
MXPA05000824A
(es)
*
|
2003-05-23 |
2005-04-28 |
Akzo Nobel Nv |
Forma de dosis farmaceutica de liberacion inmediata que contiene tibolona polimorfa.
|
ES2284068T3
(es)
*
|
2003-10-16 |
2007-11-01 |
Teva Pharmaceutical Industries Limited |
Preparacion de candesartan cilexetilo.
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
ES2300979T3
(es)
*
|
2004-01-05 |
2008-06-16 |
Teva Pharmaceutical Industries Ltd. |
Procedimiento para la produccion de sildenafilo base y de su sal citrato.
|
US7692023B2
(en)
*
|
2004-02-11 |
2010-04-06 |
Teva Pharmaceutical Industries Ltd. |
Candesartan cilexetil polymorphs
|
DE102005014706B3
(de)
*
|
2005-03-18 |
2007-01-04 |
Urs Bezold |
Kombination aus Taschenmesser und Haltevorrichtung
|
EA015155B1
(ru)
*
|
2005-05-26 |
2011-06-30 |
Тева Вуменс Хелс, Инк. |
Дозированные формы для перорального применения, содержащие прогестерон, и способы их изготовления и использования
|
US20080181966A1
(en)
*
|
2006-10-18 |
2008-07-31 |
Cephalon, Inc. |
Modafinil pharmaceutical compositions
|
US11304960B2
(en)
*
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
FR2947178B1
(fr)
*
|
2009-06-29 |
2012-07-06 |
Effik |
Composition pharmaceutique a base de progesterone micronisee et ses utilisations
|
DE102010003711B4
(de)
|
2010-04-08 |
2015-04-09 |
Jesalis Pharma Gmbh |
Verfahren zur Herstellung kristalliner Wirkstoffpartikel
|
US9375437B2
(en)
|
2010-06-18 |
2016-06-28 |
Lipocine Inc. |
Progesterone containing oral dosage forms and kits
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
US20130122051A1
(en)
*
|
2011-11-15 |
2013-05-16 |
Pharmaceutics International, Inc. |
Methods of preparing progesterone pharmaceutical compositions
|
CA2856520C
(fr)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Preparations et therapies de substitution pour hormonotherapie naturelle combinee
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CA2895529C
(fr)
|
2012-12-19 |
2018-08-21 |
Kashiv Pharma, Llc |
Nanoparticules stabilisees super saturees pour des medicaments mediocrement solubles
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
AU2015264003A1
(en)
|
2014-05-22 |
2016-11-17 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
KR20170040209A
(ko)
|
2014-07-29 |
2017-04-12 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
경피 크림
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
CN107847506A
(zh)
|
2015-06-22 |
2018-03-27 |
来普卡公司 |
含17‑羟基孕酮酯的口服组合物和相关方法
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
WO2017173044A1
(fr)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Compositions d'hormones stéroïdes dans des huiles à chaîne moyenne
|
CA3020153A1
(fr)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Composition pharmaceutique d'hormone steroide
|
EP3544614A4
(fr)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
Traitement oral à base d'undécanoate de testostérone
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|